Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25022173 |
US |
78 | |
Medication error, Blood glucose increased, Product dose omission issue, Device malfunction, Device leakage, Drug ineffective, Insurance issue, |
||||
EXENATIDE, |
||||
| 602 | 25022193 |
AU |
1 | |
Pancreatic failure, Blood glucose increased, |
||||
SEMAGLUTIDE, |
||||
| 603 | 25022229 |
US |
66 | 1 |
Aortic valve stenosis, Carotid artery stenosis, Carotid artery occlusion, Left ventricular hypertrophy, Left atrial enlargement, Swelling face, Pruritus, Eye swelling, Eye pruritus, Cerumen impaction, Large intestine polyp, Rectal polyp, Gout, Paraesthesia, Cardiac murmur, Urine flow decreased, COVID-19, Tinea pedis, Anxiety, Injection site pain, Blood glucose increased, |
||||
INSULIN DETEMIR, INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INSULIN GLARGINE, INSULIN GLARGINE, EMPAGLIFLOZIN, LISINOPRIL, LISINOPRIL, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PREDNISONE, FENOFIBRATE, CANAGLIFLOZIN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 604 | 25022433 |
US |
||
Staphylococcal infection, Joint injury, Inability to afford medication, Blood glucose increased, |
||||
DAPAGLIFLOZIN, |
||||
| 605 | 25022658 |
US |
64 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 606 | 25022837 |
CA |
54 | 2 |
Blood glucose increased, Skin lesion, |
||||
METHOTREXATE SODIUM, INFLIXIMAB, SULFASALAZINE, GOLIMUMAB, INFLIXIMAB, |
||||
| 607 | 25022850 |
CA |
||
Alanine aminotransferase increased, Blood glucose increased, Gamma-glutamyltransferase increased, Glycosylated haemoglobin increased, Hepatic steatosis, Myalgia, Neutrophil count decreased, Red cell distribution width decreased, White blood cell count decreased, |
||||
CANDESARTAN, HYDROCHLOROTHIAZIDE, |
||||
| 608 | 25023321 |
US |
||
Blood glucose increased, Hot flush, |
||||
RELUGOLIX, RELUGOLIX, TADALAFIL, ERGOCALCIFEROL, AMLODIPINE, CHLORTHALIDONE, HYDRALAZINE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, OLMESARTAN MEDOXOMIL, |
||||
| 609 | 25023676 |
US |
||
Wound, Blood glucose increased, Blindness transient, |
||||
OLEZARSEN SODIUM, |
||||
| 610 | 25023714 |
AU |
62 | 2 |
Behaviour disorder, C-reactive protein increased, Stress, Troponin increased, Eosinophil count increased, Blood albumin decreased, Blood creatinine increased, Blood thyroid stimulating hormone increased, Haemoglobin decreased, Lymphocyte count decreased, Mean cell haemoglobin decreased, Platelet count increased, White blood cell count increased, Blood osmolarity increased, Blood glucose increased, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), NITROGLYCERIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TELMISARTAN, CLOPIDOGREL BISULFATE, FLUVOXAMINE MALEATE, |
||||
| 611 | 25023797 |
US |
||
Angina pectoris, Drug eruption, Drug hypersensitivity, Toothache, Flushing, Pain in jaw, Asthenia, Decreased appetite, Decreased activity, Cardiac murmur, Blood glucose increased, Blood creatinine decreased, High density lipoprotein decreased, Blood triglycerides increased, Supraventricular extrasystoles, Platelet count increased, Peripheral swelling, Dyspnoea, Headache, Palpitations, Fatigue, Dizziness, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SACUBITRIL AND VALSARTAN, FLUCONAZOLE, DOXEPIN HYDROCHLORIDE, DIGOXIN, SPIRONOLACTONE, SERTRALINE HYDROCHLORIDE, EMPAGLIFLOZIN, TIRZEPATIDE, ROSUVASTATIN, TADALAFIL, INSULIN DEGLUDEC, CHLORPHENIRAMINE MALEATE, HYDROCODONE BITARTRATE, GABAPENTIN, ERGOCALCIFEROL, CEFDINIR, |
||||
| 612 | 25023813 |
US |
81 | 2 |
Renal failure, Vomiting, Limb injury, Urinary incontinence, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 613 | 25024119 |
US |
||
Blood glucose increased, |
||||
INSULIN HUMAN, INSULIN LISPRO, |
||||
| 614 | 25024251 |
US |
62 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 615 | 25024415 |
71 | 1 | |
Blood glucose increased, Blood creatinine increased, Fatigue, Asthenia, Dyspnoea, |
||||
INCLISIRAN, |
||||
| 616 | 25024565 |
US |
1 | |
Renal failure, Loss of consciousness, Osteoarthritis, Osteoporosis, Swollen tongue, Swelling face, Wound, Neuropathy peripheral, Micturition urgency, Pain in extremity, Peripheral vascular disorder, Mobility decreased, Tremor, Product storage error, Inappropriate schedule of product administration, Blood glucose increased, Drug ineffective, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 617 | 25024581 |
US |
80 | 1 |
Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, INSULIN GLARGINE, EMPAGLIFLOZIN, BEXAGLIFLOZIN, |
||||
| 618 | 25024834 |
US |
70 | 1 |
Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 619 | 25024836 |
US |
62 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, PREDNISONE, PREDNISONE, |
||||
| 620 | 25024871 |
US |
||
Blood glucose increased, Fatigue, Diabetes mellitus inadequate control, |
||||
ACALABRUTINIB, ACYCLOVIR, CYANOCOBALAMIN, LEVOTHYROXINE, LORATADINE, LORATADINE ORAL, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, THIAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, |
||||
| 621 | 25024926 |
RU |
63 | 1 |
Blood pressure increased, Blood glucose increased, Asthenia, Headache, |
||||
INSULIN LISPRO, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 622 | 25024943 |
US |
45 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 623 | 25024977 |
DE |
1 | |
Chronic kidney disease, Low density lipoprotein increased, Protein total increased, Blood uric acid increased, Drug intolerance, Urine protein/creatinine ratio increased, Disease recurrence, Protein urine present, Glomerulonephritis, Coronavirus infection, Reticulocyte count increased, Blood glucose increased, Blood albumin decreased, Nephrotic syndrome, Renal hypertension, Vitamin D deficiency, Proteinuria, Chronic hepatitis C, Lipoprotein (a) increased, Blood creatine phosphokinase increased, Blood creatine phosphokinase MB increased, |
||||
ROSUVASTATIN, ROSUVASTATIN, SPIRONOLACTONE, TORSEMIDE, APIXABAN, DAPAGLIFLOZIN, INCLISIRAN, BEMPEDOIC ACID, |
||||
| 624 | 25025062 |
US |
83 | |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 625 | 25025216 |
CN |
58 | 2 |
Neuroendocrine tumour, Malignant neoplasm progression, Type 2 diabetes mellitus, Diabetes mellitus inadequate control, Decreased appetite, Abdominal distension, Abdominal pain, Asthenia, Back pain, Blood glucose increased, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, DENOSUMAB, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, FENTANYL, MORPHINE, |
||||
| 626 | 25025576 |
US |
40 | 2 |
Myocardial ischaemia, Blood glucose increased, Diarrhoea, Wrong dose, Fatigue, Vomiting, Blood phosphorus increased, Brain fog, Memory impairment, Influenza, Arthralgia, Mass, Productive cough, Feeling abnormal, Sleep disorder, |
||||
LIRAGLUTIDE, INSULIN HUMAN, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, POLYETHYLENE GLYCOL 3350, |
||||
| 627 | 25025592 |
US |
50 | 2 |
Depression, Stress, Injection site pain, Drug ineffective, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, GALCANEZUMAB-GNLM, |
||||
| 628 | 25025640 |
US |
||
Myalgia, Feeling hot, Fatigue, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, TADALAFIL, SEMAGLUTIDE, LOSARTAN POTASSIUM, LOSARTAN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
| 629 | 25025665 |
US |
66 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 630 | 25031126 |
30 | 1 | |
Blood glucose increased, |
||||
IXEKIZUMAB, |
||||
| 631 | 25015750 |
US |
75 | 2 |
Blood glucose increased, Injection site pain, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 632 | 25016338 |
FR |
70 | 1 |
Cerebrovascular accident, Blood glucose increased, Product leakage, Wrong technique in product usage process, Product physical issue, |
||||
SEMAGLUTIDE, |
||||
| 633 | 25017450 |
83 | 1 | |
Anaemia, Transfusion, Sepsis, Blood lactic acid increased, Troponin I increased, Blood glucose increased, Aspartate aminotransferase increased, Blood alkaline phosphatase increased, Blood bilirubin increased, Atrial fibrillation, Ventricular extrasystoles, Bundle branch block right, Bundle branch block left, Aortic arteriosclerosis, Abdominal pain upper, Pulmonary embolism, Pleural effusion, Lung consolidation, Atelectasis, Superinfection, Neoplasm, Pleural fibrosis, Lymphadenopathy mediastinal, Pancreatic carcinoma metastatic, Metastases to liver, Post procedural complication, Bladder hypertrophy, Abdominal mass, Gallbladder disorder, Cardiac arrest, |
||||
GEMCITABINE HYDROCHLORIDE, PACLITAXEL, AMLODIPINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, FINASTERIDE, HYDROCHLOROTHIAZIDE, LISINOPRIL, POLYETHYLENE GLYCOL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 634 | 25017697 |
US |
68 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 635 | 25018202 |
US |
||
Brain injury, Seizure, Blood glucose increased, |
||||
HYDROCORTISONE, HYDROCORTISONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 636 | 25018314 |
CN |
||
Blood pressure increased, Mental disorder, Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 637 | 25018320 |
CN |
||
Blood pressure increased, Mental disorder, Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 638 | 25019362 |
US |
61 | 2 |
Pneumonia pneumococcal, Blood glucose decreased, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 639 | 25019893 |
US |
2 | |
Accidental underdose, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 640 | 25020075 |
US |
1 | |
Cough, Product supply issue, Retching, Low density lipoprotein abnormal, Rhinorrhoea, Blood glucose increased, Lacrimation increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, OLMESARTAN MEDOXOMIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, VITAMIN C, |
||||
| 641 | 25020202 |
US |
41 | 1 |
Blood glucose increased, Road traffic accident, Memory impairment, Confusional state, Extra dose administered, Injection site vesicles, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 642 | 25020277 |
US |
2 | |
Blood glucose increased, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 643 | 25020799 |
US |
||
Blood glucose increased, Amino acid level increased, Fatigue, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, PREDNISONE, |
||||
| 644 | 25020902 |
US |
1 | |
Renal cancer, Blood glucose increased, Nephropathy, Skin cancer, Lip neoplasm malignant stage unspecified, |
||||
ADALIMUMAB, INSULIN DETEMIR, INSULIN ASPART, METHYLPREDNISOLONE, |
||||
| 645 | 25021014 |
US |
6 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 646 | 25022875 |
1 | ||
Kidney transplant rejection, Blood glucose increased, |
||||
TACROLIMUS, |
||||
| 647 | 25022919 |
58 | 1 | |
Blood glucose increased, |
||||
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, |
||||
| 648 | 25011219 |
US |
32 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN ASPART, |
||||
| 649 | 25011380 |
US |
80 | 1 |
Blood glucose increased, Device leakage, Incorrect dose administered by device, Wrong technique in device usage process, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 650 | 25011545 |
IL |
40 | 1 |
Subcutaneous abscess, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
OCRELIZUMAB, EMPAGLIFLOZIN, |
||||
| 651 | 25011574 |
GB |
||
Glycosylated haemoglobin increased, Blood glucose increased, |
||||
INCLISIRAN, |
||||
| 652 | 25011604 |
US |
12 | 1 |
Addison^s disease, Polyglandular autoimmune syndrome type II, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 653 | 25012069 |
CA |
54 | 2 |
Blood glucose increased, Glycosuria, Off label use, Drug intolerance, Blood pressure increased, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE SODIUM, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
| 654 | 25012206 |
US |
83 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 655 | 25012945 |
US |
||
Urinary retention, Blood glucose increased, Urinary tract discomfort, Renal disorder, Blood urea increased, Glomerular filtration rate decreased, |
||||
OLAPARIB, |
||||
| 656 | 25013378 |
US |
2 | |
Blood glucose increased, |
||||
SITAGLIPTIN, |
||||
| 657 | 25014006 |
IN |
67 | 1 |
Weight decreased, Heart rate increased, Haemoptysis, Oedema, Blood triglycerides increased, Blood glucose increased, Blood cholesterol increased, |
||||
LORLATINIB, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, |
||||
| 658 | 25014275 |
ZA |
53 | 2 |
Injection site thrombosis, Headache, Nausea, Malaise, Restlessness, Insomnia, Blood glucose increased, Therapeutic response decreased, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 659 | 25014362 |
TR |
1 | |
Diabetic coma, Blood glucose increased, Aphasia, Off label use, |
||||
ALPELISIB, |
||||
| 660 | 25014377 |
US |
||
Blood glucose increased, |
||||
UPADACITINIB, |
||||
| 661 | 25014735 |
US |
58 | 1 |
Femur fracture, Memory impairment, Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 662 | 25014780 |
US |
66 | 2 |
Crohn^s disease, Illness, Diarrhoea, Overweight, Blood glucose increased, Product use in unapproved indication, Nausea, Abdominal distension, Abdominal pain, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, PREDNISONE, MAGNESIUM CHLORIDE, ESOMEPRAZOLE MAGNESIUM, COLCHICINE, SOTALOL HYDROCHLORIDE, GABAPENTIN, APIXABAN, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ALLOPURINOL, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 663 | 25014903 |
US |
48 | 1 |
Pleural effusion, Atelectasis, Epistaxis, Blood glucose increased, Inability to afford medication, Intentional underdose, Insurance issue, |
||||
RIFAXIMIN, RIFAXIMIN, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, SPIRONOLACTONE, SPIRONOLACTONE, LACTULOSE, LACTULOSE, LACTULOSE, ZINC SULFATE, ZINC SULFATE INJECTION,, ZINC SULFATE INJECTION, EPLERENONE, |
||||
| 664 | 25014988 |
IT |
68 | 2 |
Dyspnoea, Acute respiratory distress syndrome, Asthenia, Cough, Pyrexia, Blood chloride decreased, Blood glucose increased, Blood sodium decreased, C-reactive protein increased, Haematocrit decreased, Haemoglobin decreased, Haemoglobin distribution width increased, Lymphocyte count decreased, Neutrophil count increased, Platelet distribution width increased, Procalcitonin increased, Prothrombin time prolonged, Red blood cell count decreased, White blood cell count increased, |
||||
TRASTUZUMAB, PACLITAXEL, |
||||
| 665 | 25015015 |
US |
71 | 2 |
Product dose omission issue, Blood glucose increased, Stress, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 666 | 25015018 |
CA |
54 | 2 |
Blood glucose increased, Skin lesion, |
||||
METHOTREXATE SODIUM, SULFASALAZINE, GOLIMUMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 667 | 25015051 |
US |
63 | 1 |
Hyperphagia, Blood glucose increased, Epigastric discomfort, Abdominal pain upper, |
||||
EMPAGLIFLOZIN, TIRZEPATIDE, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 668 | 25015135 |
US |
44 | 1 |
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 669 | 25015386 |
US |
84 | 2 |
Blood glucose increased, |
||||
ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ROSUVASTATIN CALCIUM, SERTRALINE HYDROCHLORIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLONAZEPAM, TIOTROPIUM BROMIDE, INSULIN GLARGINE, INSULIN LISPRO, LEVOTHYROXINE SODIUM, ALLOPURINOL, |
||||
| 670 | 25006849 |
US |
71 | 2 |
Vision blurred, Blood glucose increased, Nausea, Constipation, |
||||
TIRZEPATIDE, |
||||
| 671 | 25006932 |
US |
79 | 2 |
Blood glucose increased, Glycosylated haemoglobin increased, |
||||
EVOLOCUMAB, |
||||
| 672 | 25006980 |
GB |
64 | 2 |
Dry mouth, Blood glucose increased, |
||||
RAMIPRIL, |
||||
| 673 | 25007151 |
US |
51 | 2 |
Blood glucose increased, Product dose omission issue, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 674 | 25007413 |
US |
44 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 675 | 25007415 |
US |
61 | 1 |
Product storage error, Blood glucose increased, Wrong product administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 676 | 25007526 |
GB |
||
Dry mouth, Blood glucose increased, |
||||
RAMIPRIL, |
||||
| 677 | 25007618 |
US |
60 | 2 |
Blood glucose increased, Accidental underdose, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 678 | 25007752 |
US |
79 | 1 |
Pancreatitis chronic, Bladder cancer, Blood urine present, Haematuria, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC AND LIRAGLUTIDE, |
||||
| 679 | 25007878 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, SEMAGLUTIDE, |
||||
| 680 | 25007919 |
DE |
1 | |
Nephrotic syndrome, Chronic kidney disease, Glomerulonephritis, Chronic hepatitis C, Blood uric acid increased, Disease recurrence, Protein total increased, Vitamin D deficiency, Renal hypertension, Lipoprotein (a) increased, Blood creatine phosphokinase increased, Proteinuria, Low density lipoprotein increased, Reticulocyte count increased, Protein urine present, Urine protein/creatinine ratio increased, Blood glucose increased, Blood albumin decreased, Blood creatine phosphokinase MB increased, Coronavirus infection, Drug intolerance, |
||||
ROSUVASTATIN, ROSUVASTATIN, INCLISIRAN, APIXABAN, TORSEMIDE, SPIRONOLACTONE, BEMPEDOIC ACID, DAPAGLIFLOZIN, |
||||
| 681 | 25008071 |
US |
1 | |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 682 | 25008186 |
GB |
64 | 2 |
Dry mouth, Blood glucose increased, |
||||
RAMIPRIL, |
||||
| 683 | 25008858 |
US |
82 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 684 | 25009586 |
US |
2 | |
Blood glucose increased, |
||||
LORATADINE, LORATADINE TABLET, |
||||
| 685 | 25009692 |
US |
39 | 2 |
Anaphylactic reaction, Blood glucose increased, Mean cell haemoglobin increased, Neutrophil count increased, Immature granulocyte count increased, White blood cell count increased, Lymphocyte count decreased, Vomiting, Abdominal pain upper, Heart rate increased, Hypocalcaemia, Condition aggravated, Swelling face, |
||||
AVAPRITINIB, |
||||
| 686 | 25009759 |
DE |
1 | |
Nephrotic syndrome, Chronic kidney disease, Glomerulonephritis, Chronic hepatitis C, Disease recurrence, Protein total increased, Vitamin D deficiency, Renal hypertension, Lipoprotein (a) increased, Drug intolerance, Blood creatine phosphokinase increased, Proteinuria, Low density lipoprotein increased, Reticulocyte count increased, Blood uric acid increased, Protein urine present, Urine protein/creatinine ratio increased, Blood glucose increased, Blood albumin decreased, Blood creatine phosphokinase MB increased, Coronavirus infection, |
||||
ROSUVASTATIN, INCLISIRAN, SPIRONOLACTONE, APIXABAN, DAPAGLIFLOZIN, BEMPEDOIC ACID, TORSEMIDE, |
||||
| 687 | 25010000 |
US |
72 | 1 |
Hypotension, Product dose omission issue, Blood glucose increased, Heart rate increased, |
||||
BUDESONIDE, |
||||
| 688 | 25010491 |
US |
63 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 689 | 25010593 |
US |
52 | 1 |
Macular degeneration, Visual impairment, Sleep disorder due to a general medical condition, Weight decreased, Sluggishness, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 690 | 25010610 |
US |
59 | 2 |
Eye haemorrhage, Therapeutic response delayed, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 691 | 25010673 |
US |
53 | 1 |
Blood glucose increased, Sleep disorder due to general medical condition, insomnia type, Injection site pain, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 692 | 25010774 |
US |
85 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 693 | 25001842 |
GB |
64 | 2 |
Dry mouth, Blood glucose increased, |
||||
RAMIPRIL, |
||||
| 694 | 25001859 |
US |
73 | 1 |
Pain in extremity, Insulin resistance, Blood glucose increased, Cough, |
||||
EVOLOCUMAB, |
||||
| 695 | 25002374 |
US |
1 | |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN GLARGINE, |
||||
| 696 | 25002485 |
US |
57 | 2 |
Blood glucose increased, Swelling face, Joint swelling, Peripheral swelling, |
||||
EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DULAGLUTIDE, INSULIN GLARGINE, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 697 | 25002850 |
US |
2 | |
Injection site pain, Blood glucose increased, Device mechanical issue, Device use issue, Intentional product misuse, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 698 | 25003298 |
US |
64 | 2 |
Pneumonia, Sinusitis, Bronchitis, Tuberculosis, Lymphocyte count decreased, Neutrophil count increased, T-lymphocyte count decreased, CD4 lymphocytes decreased, CD8 lymphocytes decreased, Blood glucose increased, Blood creatinine increased, Blood alkaline phosphatase increased, Glomerular filtration rate decreased, Total complement activity decreased, Blood immunoglobulin G decreased, Blood immunoglobulin A increased, Blood immunoglobulin M decreased, Asthma, Chronic obstructive pulmonary disease, |
||||
| 699 | 25003884 |
US |
59 | 1 |
Injection site pain, Blood glucose increased, Incorrect dose administered, |
||||
DULAGLUTIDE, |
||||
| 700 | 25004116 |
US |
79 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28